Relmada Therapeutics, Inc. (RLMD)
3.79
-0.05
(-1.30%)
USD |
NASDAQ |
Jan 15, 16:00
3.79
0.00 (0.00%)
After-Hours: 20:00
Relmada Therapeutics SG&A Expense (TTM): 28.04M for Sept. 30, 2025
SG&A Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (TTM) Benchmarks
| Amicus Therapeutics, Inc. | 353.07M |
| Invivyd, Inc. | 62.77M |
| Arcellx, Inc. | 110.28M |
| Puma Biotechnology, Inc. | 69.09M |
| NovaBay Pharmaceuticals, Inc. | 8.584M |